drugset
Drugs / Tenofovir/emtricitabine
last change Jun 2016 re-read 3 minutes ago

Tenofovir/emtricitabine

Developed for
HIV infectious disease
Investigated by
AIDS Committee of Toronto · Canadian AIDS Treatment Information Exchange · Gilead Sciences · Hassle Free Clinic · Maple Leaf Research · Toronto Metropolitan University
+1 more · Unity Health Toronto

Trials 1

today NCT02149888 · Ph 4
2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02149888 Oct 2014 → Jun 2016 HIV infectious disease Unity Health Toronto Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tenofovir/emtricitabine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02149888 ↗
Route Oral “PrEP) with oral, daily tenofovir/emtricitabine (TDF/FTC, Truvada®) is a novel biomedical approach to HIV prevention” NCT02149888 ↗